Cited by 383Reproductive tract infections researchUrinary Tract Infections ManagementGynecological conditions and treatments

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis

Open access

Cohen, Craig R., Wierzbicki, Michael R., French, Audrey L., Morris, Sheldon, Newmann, Sara, Reno, Hilary, Green, Lauri, Miller, Steve, Powell, Jonathan, Parks, Thomas, Hemmerling, Anke·2020·New England Journal of Medicine

DOI 10.1056/nejmoa1915254PMC PMC7362958

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Bacterial vaginosis affects 15 to 50% of women of reproductive age, and recurrence is common after treatment with an antibiotic agent. The high incidence of recurrence suggests the need for new treatments to prevent recurrent bacterial vaginosis. METHODS: CTV-05 (Lactin-V) to prevent the recurrence of bacterial vaginosis. Women 18 to 45 years of age who had received a diagnosis of bacterial vaginosis and who had completed a course of vaginal metronidazole gel as part of the eligibility requirements were randomly assigned, in a 2:1 ratio, to receive vaginally administered Lactin-V or placebo for 11 weeks; follow-up occurred through week 24. The primary outcome was the percentage of women who had a recurrence of bacterial vaginosis by week 12. RESULTS: CTV-05 was detected in 79% of participants in the Lactin-V group. The percentage of participants who had at least one adverse event related to Lactin-V or placebo by week 24 did not differ significantly between the groups. The percentage of participants with local or systemic adverse events was similar in the two groups. CONCLUSIONS: The use of Lactin-V after treatment with vaginal metronidazole resulted in a significantly lower incidence of recurrence of bacterial vaginosis than placebo at 12 weeks. (Funded by the National Institutes of Health; ClinicalTrials.gov number, NCT02766023.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1915254

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Inference and missing data
RUBIN, D. B. (1976) · Biometrika · doi:10.1093/biomet/63.3.581 · Cited by 9,925
Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation
Nugent, R. P., Krohn, M. A., & Hillier, S. L. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.2.297-301.1991 · Cited by 3,332
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.
Abdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., Kharsany, A. B. M., Sibeko, S., Mlisana, K. P., Omar, Z., et al. (2010) · Science · doi:10.1126/science.1193748 · Cited by 2,435
Nonspecific vaginitis
Amsel, R., Totten, P. A., Spiegel, C. A., Chen, K. C. S., Eschenbach, D. A., & Holmes, K. K. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91112-9 · Cited by 2,412
A Case–Control Study of Chorioamnionic Infection and Histologic Chorioamnionitis in Prematurity
Hillier, S. L., Martius, J., Krohn, M. A., Kiviat, N. B., Holmes, K. K., & Eschenbach, D. A. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810133191503 · Cited by 988
Vaginal Lactobacilli, Microbial Flora, and Risk of Human Immunodeficiency Virus Type 1 and Sexually Transmitted Disease Acquisition
Martin, H., Richardson, B. A., Nyange, P. M., Lavreys, L., Hillier, S. L., Chohan, B. H., Mandaliya, K. N., Ndinya‐Achola, J. O., Bwayo, J., & Kreiss, J. K. (1999) · The Journal of Infectious Diseases · doi:10.1086/315127 · Cited by 884
Cervicovaginal Bacteria Are a Major Modulator of Host Inflammatory Responses in the Female Genital Tract
Anahtar, M. N., Byrne, E. H., Doherty, K. E., Bowman, B. A., Yamamoto, H. S., Soumillon, M., Padavattan, N., Ismail, N., Moodley, A., Sabatini, M. E., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.04.019 · Cited by 814
High Recurrence Rates of Bacterial Vaginosis over the Course of 12 Months after Oral Metronidazole Therapy and Factors Associated with Recurrence
Bradshaw, C. S., Morton, A. N., Hocking, J. S., Garland, S. M., Morris, M. B., Moss, L. M., Horvath, L. B., Kuzevska, I., & Fairley, C. K. (2006) · The Journal of Infectious Diseases · doi:10.1086/503780 · Cited by 793
Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African Women
Gosmann, C., Anahtar, M. N., Handley, S. A., Farcasanu, M., Abu-Ali, G., Bowman, B. A., Padavattan, N., Desai, C., Droit, L., Moodley, A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2016.12.013 · Cited by 696

Show all 45 references

Sorted by citations

Items 201–300 of 383

Gut microbiota drives cancer evolution and therapy resistance
Min, S., Zhang, Y., Zhang, H., & Liu, Q. (2026) · Molecular Cancer · doi:10.1186/s12943-025-02564-8 · Cited by 8
Targeting vaginal dysbiosis: prospects for the application of live biotherapeutics products
Zhang, Q., Zhao, X., Chen, Z., Chen, R., Lin, X., Zhang, L., Li, K., Wang, M., Liu, Y., Zhou, H., et al. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1749581 · Cited by 5
Recurrent Infectious Vaginitis
Yazdy, G. M., Mitchell, C. M., Sobel, J. D., & Tuddenham, S. (2023) · Medical Clinics of North America · doi:10.1016/j.mcna.2023.08.017 · Cited by 5
Dysbiotic Co-Factors in Cervical Cancer. How the Microbiome Influences the Development of Cervical Intraepithelial Neoplasia (CIN)
Finzer, P., Küppers, V., & Griesser, H. (2023) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-2044-0162 · Cited by 5
Limosilactobacillus fermentum KBL674 Alleviates Vaginal Candidiasis
Jang, S. J., Jo, E. J., Lee, C., Cho, B.-R., Shin, Y. J., Song, J. S., Kim, W.-K., Lee, N., Lee, H., Park, S., et al. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10403-3 · Cited by 5
Distinct vaginal microbiome and metabolome profiles in women with preterm delivery following cervical cerclage
Zhang, J., Li, L., Zhang, M., Fang, J., Xu, Z., Zheng, Y., Lin, Z., & Pan, M. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1444028 · Cited by 6
Reconceptualizing bacterial vaginosis treatment
Masson, L., Abrahams, A. G., & Manhanzva, M. T. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01063-6 · Cited by 5
Editorial: New techniques in microbiome research - volume II: Host-microbiome interactions using ‘meta-omics’ techniques
Lin, T. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1541881 · Cited by 5
Optimizing Maternal Microbiome: Role in Improved Conception and Pregnancy Outcome
Barnea, E. R., Nazareth, A. K., Purandare, C. N., Borovac‐Pinheiro, A., Carluccio, R. D., Purandare, N. C., & McAuliffe, F. M. (2026) · Reproductive Medicine and Biology · doi:10.1002/rmb2.70014 · Cited by 5
Vaginal Microbiome Research Consortium for Africa: study protocol of a multicentre prospective clinical study to evaluate temporal vaginal microbial composition associated with maintenance of reproductive health in women in South Africa and Kenya
Kullin, B., Gitome, S. W., Happel, A., Pidwell, T., Lefevre, M., Madikida, A., Wekesa, P., Mahlangu, K., Ochieng, J., Awili, L., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-090938 · Cited by 4
Through thick and thin: The vaginal microbiome as both occupant and healer
Sillen, M., Lebeer, S., & Dijck, P. V. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013346 · Cited by 4
Bacterial vaginosis: advancing insights into microbial dysbiosis
Liu, D., Zhang, X., Zhao, X., Che, X., Song, W., & Wu, G. (2025) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2025.2537923 · Cited by 6
Cervicovaginal microbiome alters transcriptomic and chromatin accessibility signatures across cervicovaginal epithelial barriers
Anton, L., Cristancho, A. G., Ferguson, B., Ravel, J., & Elovitz, M. A. (2025) · Microbiome · doi:10.1186/s40168-025-02223-6 · Cited by 6
Female reproductive microbiome in fertility care
Dash, S., Zhao, D., Schuppe‐Koistinen, I., & Du, J. (2026) · Fertility and Sterility · doi:10.1016/j.fertnstert.2026.02.015 · Cited by 5
Sustained dual delivery of metronidazole and viable Lactobacillus crispatus from 3D-printed silicone shells
Kyser, A. J., Mahmoud, M. Y., Fotouh, B., Patel, R., Armstrong, C. N., Aagard, M. A., Rush, I., Lewis, W. G., Lewis, A. L., & Frieboes, H. B. (2024) · Biomaterials Advances · doi:10.1016/j.bioadv.2024.214005 · Cited by 4
Persistent Bacterial Vaginosis and Risk for Spontaneous Preterm Birth
Blumenfeld, Y. J., Marić, I., Stevenson, D. K., Gibbs, R. S., & Shaw, G. M. (2023) · American Journal of Perinatology · doi:10.1055/s-0043-1770703 · Cited by 4
A clinical report highlighting some factors influencing successful vaginal colonization with probiotic Lactobacillus crispatus
Pierro, F. D., Bertuccioli, A., Cazzaniga, M., Zerbinati, N., & Guasti, L. (2023) · Minerva Medica · doi:10.23736/s0026-4806.23.08773-6 · Cited by 4
The Other U = U: Untested and Untreated Genital Tract Inflammation in People Living With and Exposed to Human Immunodeficiency Virus
Chitneni, P. R., & Matthews, L. T. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab074 · Cited by 4
Preclinical validation of electrospun fibers to achieve vaginal colonization by Lactobacillus crispatus
Armstrong, C. N., Saha, S., Aagard, M. A., Mahmoud, M. Y., Varki, N. M., Gilbert, N. M., Frieboes, H. B., Lewis, W. G., & Lewis, A. L. (2025) · Frontiers in Bacteriology · doi:10.3389/fbrio.2025.1562077 · Cited by 3
Portable fully integrated POCT device based on digital microfluidic technology
Hou, J., Li, F., Zhang, S., Ai, X., Yang, F., Zhou, T., Guo, Z., Zhao, T., Li, H., Zhang, S., et al. (2025) · Biomedical Instrumentation · doi:10.1016/j.bmi.2025.100001 · Cited by 3
The infectome framework: linking polymicrobial ecology and biofilm dynamics to precision diagnostic approaches
Saleh, R. M., & Hassan, O. M. (2025) · Infection · doi:10.1007/s15010-025-02687-6 · Cited by 3
A Dive into the Invisible: The Vaginal and Endometrial Microbiota in Gynecologic and Obstetric Disorders: A Narrative Review
Schettini, G., Pieri, E., Rizzo, C., Giorgi, M., Mancini, V., Habib, N., Rovira, R. P., & Centini, G. (2026) · Life · doi:10.3390/life16020344 · Cited by 7
Pangenome-based design of strain-specific primers enables precise monitoring of bacteria in human microbiome intervention trials
Eilers, T., Delanghe, L., Boeck, I. D., Rillaer, T. V., Malderen, J. V., Bakelants, S., Beeck, W. V., Wittouck, S., & Lebeer, S. (2026) · Scientific Reports · doi:10.1038/s41598-026-41449-8 · Cited by 3
Machine learning-based prediction of BV-relevant probiotic functional potential in vaginal-derived Lactobacillus crispatus strains
Quan, K., Liu, W. J., Jin, H., Hu, W., Borjihan, Q., Bao, Q., & Chen, Y. (2026) · BMC Microbiology · doi:10.1186/s12866-026-04873-4 · Cited by 3
Electrospun nanofibers for antibiotic and probiotic co-delivery to target bacterial vaginosis
Verhoeven, D., Kyser, A. J., Greiner, A., Lewis, W. G., Lewis, A. L., & Frieboes, H. B. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.127023 · Cited by 3
Does Bacterial Vaginosis Contribute to Urinary Tract Infection?
Handa, V. L., Brotman, R. M., Ravel, J., & Tuddenham, S. (2023) · Current Infectious Disease Reports · doi:10.1007/s11908-022-00795-0 · Cited by 3
Microbiota disorders in bacterial vaginosis and the possibility of personalized therapy of the disease with the use of probiotics (review)
Klimov, N. A., & Shamova, O. V. (2023) · Russian Journal for Personalized Medicine · doi:10.18705/2782-3806-2022-2-6-78-90 · Cited by 3
Bacterial vaginosis: modern aspects of pathogenesis, diagnosis, and treatment
Dobrokhotova, Y. E., Дмитриевна, К. В., & Ozolinya, L. A. (2023) · V F Snegirev Archives of Obstetrics and Gynecology · doi:10.17816/2313-8726-2023-10-3-209-218 · Cited by 4
Ecology meets reproductive medicine in HIV prevention: the case for geography-informed approaches for bacterial vaginosis in Africa
Passmore, J.-A. S., Ngcapu, S., Gitome, S. W., Kullin, B., Welp, K., Martin, D. P., Potloane, D., Manhanzva, M. T., Obimbo, M., Gill, K., et al. (2024) · Frontiers in Reproductive Health · doi:10.3389/frph.2024.1431306 · Cited by 3
Interactions between the epithelial barrier and the microbiota in the reproductive tract
Takada, K., Komine‐Aizawa, S., Tsuji, N. M., & Hayakawa, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818508-7.00002-6 · Cited by 3
Novel insights in bacterial vaginosis etiology through genomic approaches
de Almeida, M. O., Viana, M. V. C., Cerqueira, J. C., Aburjaile, F. F., Zamyatnin, A. A., Azevedo, V., & Carvalho, R. D. D. O. (2021) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202120200945 · Cited by 5
Vaginal Lactobacillus fatty acid response mechanisms reveal a novel strategy for bacterial vaginosis treatmentPreprint
Zhu, M., Frank, M. W., Radka, C. D., Jeanfavre, S., Tse, M. W., Ávila-Pacheco, J., Pierce, K. A., Deik, A., Xu, J., Hussain, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.30.573720 · Cited by 3
Pangenome-based design of strain-specific primers allows the specific monitoring of engraftment in different habitatsPreprint
Lebeer, S., Eilers, T., Delanghe, L., Boeck, I. D., Rillaer, T. V., Malderen, J. V., Bakelants, S., Beeck, W. V., & Wittouck, S. (2024) · Research Square · doi:10.21203/rs.3.rs-4182624/v1 · Cited by 3
VIBRANT: Vaginal lIve Biotherapeutic RANdomized Trial: A Phase 1 randomized trial of multi-strain vaginal L. crispatus live biotherapeutic products in people with bacterial vaginosisPreprint
Potloane, D., Symul, L., Ngcapu, S., Lewis, L., France, M., Vermeren, L., Elsherbini, J., Chetty, C., Mafunda, N. A., Polliah, A. M., et al. (2025) · medRxiv · doi:10.1101/2025.09.18.25336053 · Cited by 3
Circulating Short-Chain Fatty Acids: Association with Vaginal Microbiota, Genital Inflammation, and HIV Acquisition
Shivakoti, R., Letsoalo, M. P., Lewis, L., McKinnon, L. R., Passmore, J.-A. S., Karim, S. S. A., & Liebenberg, L. J. P. (2025) · AIDS Research and Human Retroviruses · doi:10.1177/08892229251366174 · Cited by 2
The female microbiome in HIV prevention, pathogenesis, and treatment
Peters, B. A., Usyk, M., & Burk, R. D. (2025) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000986 · Cited by 2
Vaginal Weissella confusa MV0113 suppresses pathogens and restores microbiota to alleviate bacterial vaginosis: integrated genomic and in vivo evidence
Luo, C., Dong, X., Song, J., Li, Y., Zhang, Q., Pang, Y., Yue, B., Tao, G. U. O., & Fan, Z. (2025) · BMC Microbiology · doi:10.1186/s12866-025-04552-w · Cited by 2
The human reproductive tract microbiome: A novel source of live biotherapeutics
Narendrakumar, L., Dhiman, P., & Das, B. (2026) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2026.01.027 · Cited by 2
Partner treatment in women with bacterial vaginosis: an update to the International Society for the Study of Vulvovaginal Disease (ISSVD) recommendations
Vieira‐Baptista, P., Stockdale, C. K., & Sobel, J. D. (2026) · Sexually Transmitted Infections · doi:10.1136/sextrans-2025-056813 · Cited by 2
The vaginal microbiome in pregnancy and preterm birth: mechanisms, disparities, and therapeutic opportunities
Pillay, N., Short, C.-E. S., Mzobe, G. F., Mtshali, A., & Ngcapu, S. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-026-00945-5 · Cited by 4
Precision Microbial Therapeutics for Infertility: Next‐Generation Probiotics, Engineered Biologics and Translational Pathways
Li, L., Feng, L., Li, Q., Zhou, Y., Liu, S., Song, H., Kang, S., Chen, H., Cong, H., & Liu, S. (2026) · Microbial Biotechnology · doi:10.1111/1751-7915.70330 · Cited by 2
Microbial chassis selection for niche-specific engineered live biotherapeutics
Byun, D., Lee, L. T., Zhang, C., Aggarwal, N., & Chang, M. W. (2026) · Current Opinion in Microbiology · doi:10.1016/j.mib.2026.102748 · Cited by 2
Innate Immunity and Microbial Recognition in Reproduction: From Barrier Defense to Maternal–Fetal Tolerance
Rao, X., Zou, L., Yao, Y., & Liu, C. (2026) · The FASEB Journal · doi:10.1096/fj.202601196r · Cited by 2
The impact of prenatal use of oral Clostridium butyricum on maternal group B Streptococcus colonization: A retrospective study
Lai, T.-J., Wang, Y., Chong, E., Lin, Y.-M., Huang, C.-C., Feng, K.-J., & Teng, S. (2021) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2021.03.009 · Cited by 2
Cultivable vaginal Lactobacillus is not associated with fecundability in Kenyan women attempting to conceive
Lokken, E. M., Jisuvei, C. S., Hughes, J. P., Mandaliya, K. N., Manhart, L. E., Mwinyikai, K., MULLER, C. H., Jaoko, W. G., Kinuthia, J., & McClelland, R. S. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2021.11.032 · Cited by 2
Role of Microbiome in Reproductive Health: An Expanding Dimension
Pushkarna, S., Bhatnager, R., Kumar, A., Suneja, P., & Dang, A. S. (2023) · Springer eBooks · doi:10.1007/978-981-99-3126-2_16 · Cited by 2
Bacterial vaginosis and associated bacteria
McLaughlin, S. E., Strenk, S. M., & Fredricks, D. N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00109-x · Cited by 3
The prevalence of vulvovaginal symptoms in Japanese women of reproductive and perimenopausal ages: A cross‐sectional study across generations
Kawai, T., Harada, M., Yamada, K., Ugomori, R., & Osuga, Y. (2024) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15917 · Cited by 2
An in silico framework for the rational design of vaginal probiotic therapy
Lee, C. Y., Bonakdar, S., & Arnold, K. B. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012064 · Cited by 2
Acceptability of the live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) among young women at high risk of HIV acquisition in South Africa: data from the phase 2 placebo-controlled trial
Hemmerling, A., Govender, V., Dong, K. L., Dong, M., Pillay, S., Ndung’u, T., Bhoola, A., Moodley, J., Casillas, G., Lagenaur, L. A., et al. (2025) · Frontiers in Reproductive Health · doi:10.3389/frph.2025.1544458 · Cited by 2
Self-citation
Emerging Insights Into Microbiome Therapeutics for Urinary Tract Infections: A Narrative Review
Seo, H., Rahim, M. A., Barman, I., Hossain, M. S., Tajdozian, H., Ghorbanian, F., Shuvo, M. S. H., Choi, J., Kim, S., Yang, H. J., et al. (2025) · Urogenital Tract Infection · doi:10.14777/uti.2448034017 · Cited by 3
Factors associated with Nugent-bacterial vaginosis in pregnancy and postpartum among women in rural northwestern Bangladesh
Kan, L., Tuddenham, S., Christian, P. S., Massie, A. B., Labrique, A. B., Wu, L. S. F., Ali, H., Rashid, M., Gough, E. K., Chakraborty, S., et al. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004768 · Cited by 2
Common cervicovaginal sequencing methods result in discordant molecular diagnoses of bacterial vaginosis and reveal strain level effects of Gardnerella vaginalis
Broedlow, C. A., Swanson, E., Cherenack, E. M., Basting, C. M., Nogueira, N. F., France, M., Yue, P., Chakrawarti, A., Salazar, A. S., Acosta, L., et al. (2025) · npj Women s Health · doi:10.1038/s44294-025-00089-5 · Cited by 2
The Role of Cervicovaginal Microbiota and Probiotics in Modulating HPV Persistence and Preventing Cervical Cancer
Medina-Rivero, A. S., Ratkovich-González, S., Ruiz-Briseño, M. D. R., & Rosas‐González, V. C. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c00385 · Cited by 4
The Endometrial Microbiota’s Role in Fertility: Updates and Future Directions
Lee, A. H., Dundee, J., & Esfandiari, N. (2024) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-024-00374-1 · Cited by 2
Impacto en la salud materno fetal de embarazadas adolescentes con vaginosis bacteriana
Ortiz, J. B. M., Franco-Macias, M. O., -Mariscal, L. A. S., & Garcia-Ortega, M. G. (2024) · MQRInvestigar · doi:10.56048/mqr20225.8.1.2024.5041-5264 · Cited by 2
Recent Advances and New Challenges in Cisgender Women’s Gynecologic and Obstetric Health in the Context of HIV
Deese, J., Heffron, R. A., Jaspan, H. B., Masson, L., Smit, J. A., & Sibeko, S. (2021) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000627 · Cited by 2
Vaginosis Bacteriana – Actualización y novedad terapéutica
Morgan, J. P. S., Moya, L. C. A., & Mendez, E. A. G. (2022) · Revista Ciencia y Salud Integrando conocimientos · doi:10.34192/cienciaysalud.v5i6.387 · Cited by 2
Cancer-associated Lactobacillus iners are genetically distinct and associated with chemoradiation resistance in cervical cancerPreprint
Colbert, L. E., Karpinets, T. V., Alam, M. B. E., Lynn, E. J., Sammouri, J., Lo, D., Elnaggar, J. H., Wang, R., Harris, T., Yoshida-Court, K., et al. (2022) · medRxiv · doi:10.1101/2022.04.26.22274346 · Cited by 2
Does intervention with clindamycin and a live biotherapeutic drug containing Lactobacillus crispatus impact the reproductive outcome of IVF patients with abnormal vaginal microbiota: a randomised double-blind, placebo-controlled multicentre trialPreprint
Haahr, T., Freiesleben, N. L. C., Jensen, M., Elbæk, H. O., Alsbjerg, B., Laursen, R., Prætorius, L., Nielsen, H. S., Pinborg, A. B., Hartvig, V., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4271948/v1 · Cited by 2
Can probiotics replace antibiotics? Not yet, says the evidence
Łukasik, J., & Szajewska, H. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2025.2499485 · Cited by 2
Donation strain engraftment demonstrates feasibility of vaginal microbiota transplantation to prevent recurrent bacterial vaginosisPreprint
Hussain, F. A., Bergerat, A., Kelly, J., Demidkina, B. C., Worrall, D. P., Xu, J., Kannan, A., Brunner, T. H., Culler, N., Goldenberg, M., et al. (2025) · medRxiv · doi:10.1101/2025.08.27.25334544 · Cited by 2
Vitamin D supplementation in bacterial vaginosis
Татарчук, Т. Ф., Kaluginа, L. V., Kvasha, T. I., & Mnevets, R. O. (2023) · Reproductive Endocrinology · doi:10.18370/2309-4117.2023.68.36-42 · Cited by 1
Remote BV Management via Metagenomic Vaginal Microbiome Testing and Telemedicine
Thomas-White, K. J., Lyttle, D., Olmschenk, G., Markowitz, R., Navarro, P., & McLean, K. (2025) · Microorganisms · doi:10.3390/microorganisms13071623 · Cited by 1
Vaginales Mikrobiom und Infertilität – diagnostische und therapeutische Relevanz
von der Halben, P., & Finzer, P. (2025) · Die Gynäkologie · doi:10.1007/s00129-025-05397-0 · Cited by 1
Microbiome therapeutic PMC101 inhibits the translocation of carbapenem-resistant Klebsiella while enhancing eubiosis in antibiotic-induced dysbiosis mice
Tajdozian, H., Seo, H., Kim, S., Rahim, M. A., Park, H. A., Sarafraz, F., Yoon, Y., Kim, H., Barman, I., Park, C.-E., et al. (2025) · Medical Microbiology and Immunology · doi:10.1007/s00430-025-00858-8 · Cited by 1
Associations between Nugent‐bacterial vaginosis and preterm birth and other adverse pregnancy outcomes in rural northwestern Bangladesh
Erchick, D. J., Tuddenham, S., Kan, L., Wu, L. S. F., Labrique, A. B., Ali, H., Gough, E. K., Rashid, M., Siddiqua, T. J., Chakraborty, S., et al. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70691 · Cited by 1
Vaginal‐Derived Potential Probiotics and Their Postbiotics Alleviate Aerobic Vaginitis via Suppressing TLR4 / MyD88 / NF ‐ κB Signalling Pathway and Potentially Enhancing Vaginal Barrier
Tian, M., Zhang, X., Xu, X., He, X., Wu, X., Wei, J., Tan, B., & Chen, T. (2026) · Microbial Biotechnology · doi:10.1111/1751-7915.70327 · Cited by 1
Vaginal Probiotic Potential of the Nomadic Species Limosilactobacacillus fermentum Under Dysbiotic Vaginal Conditions: Population Genomic Insights and Anti-Pathogenic Efficacy of a Vaginal Isolate VL9
Che, Y., Mao, Y., Li, M., Liu, X., Li, H., Yan, G., Gao, H., Bai, X., Sun, Z., Liu, X., et al. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11000-2 · Cited by 1
The vaginal microbiome and HIV acquisition risk
Masson, L., Radzey, N., Abrahams, A. G., Ngcapu, S., McKinnon, L. R., & Jaspan, H. B. (2026) · The Lancet HIV · doi:10.1016/s2352-3018(26)00032-9 · Cited by 1
Role of the penile microbiome in female sex partner risk of bacterial vaginosis and sexually transmitted infections: a narrative review
Mehta, S. D. (2026) · Clinical Microbiology Reviews · doi:10.1128/cmr.00331-25 · Cited by 1
Lactobacillus Vaginal Tablets in Preventing Recurrence of Bacterial Vaginosis: A Systematic Review and Meta-Analysis
Awasthi, Y., Bangar, S. D., Boopalan, D., Karuppiah, M., & Ponnaiah, M. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11026-6 · Cited by 1
Computational identification of antigens and development of a multi-epitope vaccine for bacterial vaginosis caused by Gardnerella vaginalis
Niknezhad, M. A., Doosti, A., & Shakhsi‐Niaei, M. (2026) · Amino Acids · doi:10.1007/s00726-026-03537-x · Cited by 1
Bacterial vaginosis and specific high-risk human papillomavirus genotype infection: a cross-sectional study in Nairobi, Kenya
Chibvongodze, R., Kyama, M. C., & Muchiri, L. (2026) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2026.1816885 · Cited by 1
The role of probiotics in restoring and maintaining vaginal microbiome health: a review
Sahu, B. K., Panda, S. K., Mallick, U., Panda, S. H., & Sahu, M. C. (2026) · Infection and Immunity · doi:10.1128/iai.00011-26 · Cited by 2
HIV Transmission and Immunology of the Male Reproductive Tract
Tsang, J., Liu, R., Jamil, R., Galiwango, R. M., Okech, B. A., Huibner, S., de Carvalho, M. G. A., Buchanan, L. B., Liu, C. M., Tobian, A. A. R., et al. (2026) · American Journal of Reproductive Immunology · doi:10.1111/aji.70266 · Cited by 1
Intravaginal Formulation Strategies for Vaginal Disorders: Optimizing Phytochemical and Biological Preparations—A Review
Hwang, J. H., & Nam, E.-Y. (2026) · Molecules · doi:10.3390/molecules31152676 · Cited by 1
Role of Obesity in Recurrent Vulvovaginal Symptoms and Disease
Powell, A. M., Sarria, I., & Goje, O. (2022) · Current Infectious Disease Reports · doi:10.1007/s11908-022-00793-2 · Cited by 1
The Role of Probiotics in Preventing Recurrent Bacterial Vaginosis and Vulvovaginal Candidiasis: A Literature Review
Fitri, A. N., Nastiti, N. P., Kurniawati, E. M., & Wiyasihati, S. I. (2022) · International Journal of Research Publications · doi:10.47119/ijrp10011511220224347 · Cited by 1
Achieving Effective Probiotic Therapy in Bacterial Vaginosis—Still an Unanswered Priority?
Sobel, J. D. (2024) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001967 · Cited by 1
Treating PPH: A novel vacuum-induced hemorrhage control device
Gibson, K. S., & Kominiarek, M. A. (2021) · OBG Management · doi:10.12788/obgm.0065 · Cited by 1
A case of BV during pregnancy: Best management approach
Reeder, C. F., & Duff, P. (2021) · OBG Management · doi:10.12788/obgm.0073 · Cited by 1
Considerations for Choosing Soluble Immune Markers to Determine Safety of Novel Vaginal Products
Happel, A., Sivro, A., Liebenberg, L. J. P., Passmore, J.-A. S., & Mitchell, C. M. (2022) · Frontiers in Reproductive Health · doi:10.3389/frph.2022.899277 · Cited by 1
The Effectiveness of Lactobacillus crispatus Probiotics as Prophylactic Therapy for Bacterial Vaginosis Recurrence: A Systematic Review and Meta-analysis
(2022) · American Journal of Dermatological Research and Reviews · doi:10.28933/ajodrr-2022-06-0505ia · Cited by 1
Benefits and limitations of clinical assessment of abnormal vaginal discharge etiology
Tutchenko, T. М., Татарчук, Т. Ф., Borysova, L. О., & Chaykivska, E. F. (2023) · Reproductive Endocrinology · doi:10.18370/2309-4117.2023.68.48-56 · Cited by 1
Computational modeling of 3D-printed Lactobacillus-antibiotic scaffolds for bacterial vaginosis.
Rai, V. (2021) · doi:10.18297/etd/3917 · Cited by 1
Predicting Bacterial Vaginosis Development using Artificial Neural NetworksPreprint
Elnaggar, J. H., Lammons, J. W., Ardizzone, C. M., Aaron, K. J., Jacobs, C., Graves, K. J., George, S. D., Luo, M., Tamhane, A. R., Łaniewski, P., et al. (2025) · medRxiv · doi:10.1101/2025.05.02.25326872 · Cited by 1
StrainFacts accurately quantifies both endogenous and live biotherapeutic product strain abundances in simulated and clinical vaginal microbiota samplesPreprint
Shih, J. B., Bloom, S. M., Xu, J., Mitchell, C. M., Elsherbini, J., & Kwon, D. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.15.670563 · Cited by 1
kSanity: A k-mer based application for precision bacterial strain detection and quantificationPreprint
France, M., Chaudry, I., Elsherbini, J., & Ravel, J. (2025) · bioRxiv · doi:10.1101/2025.09.04.674052 · Cited by 1
Bakterielle Vaginosis: Lactin-V reduziert das Risiko von Rezidiven
Steurer, J. (2020) · Praxis · doi:10.1024/1661-8157/a003560
Management of Recurrent Bacterial Vaginosis
Cymring, B. (2021)
Treatment of persistent bacterial vaginosis and risk for spontaneous preterm birthPreprint
Blumenfeld, Y. J., Marić, I., Stevenson, D. K., Gibbs, R. S., & Shaw, G. M. (2021) · doi:10.22541/au.161784971.11994862/v1
A Summary of the Sixth International Workshop on Microbiome in HIV Pathogenesis, Prevention, and Treatment
Sherrill-Mix, S. A., Yang, M. X., Aldrovandi, G. M., Brenchley, J. M., Bushman, F. D., Collman, R. G., Dandekar, S., Klatt, N. R., Lagenaur, L. A., LANDAY, A. L., et al. (2021) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2021.0173
Presentation, Diagnosis and Treatment of Mixed Vaginitis
Perveen, S., Shah, F., Zaman, S., Mahmood, F., Azhar, M. S., & Mahmood, U. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22162148
Inflammation, HIV, and Immune Quiescence: Leveraging on Immunomodulatory Products to Reduce HIV Susceptibility
Archary, D., & Cromarty, R. T. (2022) · Advanced Biomedicine · doi:10.54730/abm.2022.040101
Blurring the line between opportunistic pathogens and commensals
Jia, H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91369-0.00007-8 · Cited by 1
Bakterielle Vaginose: Rückfallprophylaxe mit Lactobacillus crispatus
(2020) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-1183-1167
Peran Probiotik terhadap Tingkat Rekurensi Bakterial Vaginosis
Kuncoro, C. S. (2022) · Jurnal Health Sains · doi:10.46799/jhs.v3i8.544
Fabrication and characterization of Lactobacillus Crispatus containing bioprints for bacterial vaginosis application.
Kyser, A. J. (2022) · doi:10.18297/etd/3922
Zusammenspiel von Mikrobiom und Immunsystem im Rahmen der Reproduktion
Vomstein, K. (2023) · Gynäkologische Endokrinologie · doi:10.1007/s10304-023-00535-0

Authors: Cohen, C. R., Wierzbicki, M. R., French, A. L., Morris, S., Newmann, S., Reno, H., Green, L., Miller, S., Powell, J., Parks, T., & Hemmerling, A.
Affiliations: University of California, San Francisco (US)
Rush University Medical Center (US)
ORCID: Cohen, Craig R.
French, Audrey L.
Newmann, Sara
Reno, Hilary
Green, Lauri
Miller, Steve
Parks, Thomas
Hemmerling, Anke
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2020-05-14
Volume: 382
Issue: 20
Pages: 1906-1915
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1915254
PMC: PMC7362958
OpenAlex: W3024851520
Cited by: 377
References: 45
Citations by year: 2026: 71 · 2025: 70 · 2024: 55 · 2023: 60 · 2022: 47 · 2021: 52 · 2020: 22
FWCI: 33.29
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.nejmgroup.org/legal/terms-of-use.htm (vor)
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Institute of Allergy and Infectious Diseases (HHSN272201300014I/HHSN27200007)
Topics: Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
Health Sciences › Medicine › Urology › Urinary Tract Infections Management
Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords: bacterial vaginosis, recurrence prevention, vaginal probiotics, Lactobacillus, metronidazole, vaginal treatment, adverse events
MeSH terms: Lactobacillus crispatus, Administration, Intravaginal, Adolescent, Adult, Antibiosis, Anti-Bacterial Agents, Double-Blind Method, Female, Gels, Humans, Metronidazole, Middle Aged, Vagina, Incidence, Vaginosis, Bacterial, Secondary Prevention, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks